Details for New Drug Application (NDA): 050176
✉ Email this page to a colleague
NDA 050176 describes NEOSPORIN, which is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in three NDAs. Additional details are available on the NEOSPORIN profile page.
The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 050176
| Tradename: | NEOSPORIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 3.5MG BASE/GM;10,000 UNITS/GM | ||||
| Approval Date: | Jan 14, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
